Skip to main content

Early Money: A startup that wants to turn immune cells into factories to fight cancer raised $73M in a Series A

Walking Fish Therapeutics hopes to tap into the productive power of B cells.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.